SEC Form 4 · accession 0000899866-19-000022
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bazarko
Officer — SVP, Controller, CAO
Period of report
Feb 14, 2019
Accepted (ET)
Feb 19, 2019 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share | Feb 14, 2019 | S | 2,000 | $126.00 | D | 5,020 | D |
Table II — derivative securities
No Table II lines on this filing.